Skip to main content
. 2019 Sep;11(Suppl 14):S1789–S1799. doi: 10.21037/jtd.2019.08.54

Table 1. Updated clinical classification of pulmonary hypertension (PH) (adapted from 6th WSPH document).

PAH
   Idiopathic PAH
   Heritable PAH
   Drug- and toxin-induced PAH (Table 2)
   PAH associated with
      Connective tissue disease
      HIV infection
      Portal hypertension
      Congenital heart disease
      Schistosomiasis
   PAH long-term responders to calcium channel blockers
   PAH with overt features of venous/capillaries (PVOD/PCH) involvement
   Persistent PH of the newborn syndrome
PH due to left heart disease
   PH due to heart failure with preserved LVEF
   PH due to heart failure with reduced LVEF
   Valvular heart disease
   Congenital/acquired cardiovascular conditions leading to post-capillary PH
PH due to lung diseases and/or hypoxia
   Obstructive lung disease
   Restrictive lung disease
   Other lung disease with mixed restrictive/obstructive pattern
   Hypoxia without lung disease
   Developmental lung disorders
PH due to pulmonary artery obstructions
   Chronic thromboembolic PH
   Other pulmonary artery obstructions
      Sarcoma (high or intermediate grade) or angiosarcoma
      Other malignant tumours
           Renal carcinoma
           Uterine carcinoma
           Germ cell tumours of the testis
           Other tumours
      Non-malignant tumours: uterine leiomyoma
      Arteritis without connective tissue disease
      Congenital pulmonary artery stenoses
      Parasites
PH with unclear and/or multifactorial mechanisms
   Haematological disorders: chronic haemolytic anaemia myeloproliferative disorders
   Systemic and metabolic disorders: pulmonary Langerhans cell histiocytosis, Gaucher disease, glycogen storage disease, neurofibromatosis, sarcoidosis
   Others: chronic renal failure with or without hemodialysis, fibrosing mediastinitis
   Complex congenital heart disease
      Segmental pulmonary hypertension: isolated pulmonary artery of ductal origin, absent pulmonary artery, pulmonary atresia with ventricular septal defect and major aorto-pulmonary collateral arteries, hemitruncus, other
      Single ventricle: unoperated, operated
      Scimitar syndrome

PAH, pulmonary arterial hypertension; PVOD, pulmonary veno-occlusive disease; PCH, pulmonary capillary haemangiomatosis; LVEF, left ventricular ejection fraction.